Low-Dose Interleukin-2 Ameliorates Colitis in a Preclinical Humanized Mouse Model.

TitleLow-Dose Interleukin-2 Ameliorates Colitis in a Preclinical Humanized Mouse Model.
Publication TypeJournal Article
Year of Publication2019
AuthorsGoettel, JA, Kotlarz, D, Emani, R, Canavan, JB, Konnikova, L, Illig, D, Frei, SM, Field, M, Kowalik, M, Peng, K, Gringauz, J, Mitsalis, V, Wall, SM, Tsou, A, Griffith, AE, Friedman, JR, Towne, JE, Plevy, SE, Hall, AO'Hara, Snapper, SB
JournalCell Mol Gastroenterol Hepatol
Date Published2019 May 09
ISSN2352-345X
DOI10.1016/j.jcmgh.2019.05.001
Alternate JournalCell Mol Gastroenterol Hepatol
PubMed ID31078723